GET DAILY SIGNALSOnce Upon a Farm (OFRM): Assessing the Road to the $16 Analyst Target (+59% Potential)
Key Takeaways
- The central target of $16 is the rounded average analyst price target for OFRM, with the underlying mean near $16.17 across roughly ten analyst estimates.
- With the stock trading around $10, reaching $16 implies a roughly 59% gain, a very large move from current levels.
- Published targets span a wide range; the most recent individual targets sit at $19 (Barclays) and $23 (Evercore ISI), while early 2026 coverage ranged from about $17 to $43.
- The strongest supporting factors are rapid revenue growth, an expanding organic baby and kids food category, and a net-cash balance sheet.
- The biggest risks are continued losses, elevated short interest, a steep post-IPO decline, and downward analyst target revisions.
- You can find more detail on this ticker's Major News, Today's Price Move, Forecast, and Earnings on additional pages.
- Explore Trending AI Robots to see how AI-driven trading tools are tracking opportunities like this one.
Understanding the Analyst Consensus on OFRM
Once Upon a Farm, PBC (OFRM) is a Berkeley, California-based maker of organic baby, toddler, and kids nutrition products, including cold-pressed pouches, frozen meals, and soft-baked bars. It completed its initial public offering on the New York Stock Exchange in February 2026 at $18.00 per share.
The $16 central target reflects the average of analyst price targets, with the underlying mean reported near $16.17 across roughly ten estimates. That average has fallen sharply from the mid-$20s level seen during the first months of coverage, mirroring the stock's own decline from its $27.00 high. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Individual views remain split. Barclays' Andrew Lazar most recently held an Equal-Weight rating with a $19 target, while Evercore ISI's David Palmer maintained an In-Line rating at $23. These represent the two most current, verifiable targets. Earlier 2026 initiations were far more spread out, with Deutsche Bank on the low end near $17 and Goldman Sachs as high as $43, while William Blair began coverage with a Buy rating. That wide dispersion signals genuine disagreement about how much the company's growth can offset its losses.
Where OFRM Stands Today and the Path to $16
OFRM closed near $10 in mid-November 2026, toward the lower end of its 52-week range of $8.83 to $27.00. Reaching the $16 target would require a gain of approximately 59%, which is a very large move rather than an incremental one. In practical terms, the stock would need to retrace most of its October-to-November decline and reclaim the $15-to-$16 zone where it traded for much of the second half of 2026.
The company's fundamentals are a study in contrast. Trailing twelve-month revenue of roughly $288 million grew more than 40% year over year, but the business still posted a net loss, with negative EPS (earnings per share) and no current P/E (price-to-earnings) ratio to anchor valuation. The stock is therefore being priced on growth, cash runway, and execution rather than on current profitability.
Factors That Could Support a Move Higher
- Strong top-line momentum: Revenue growth has remained robust, and the organic baby and kids food category continues to gain share in mainstream retail.
- Balance-sheet flexibility: With roughly $93 million in cash and minimal debt, the company has runway to fund growth without immediate dilution pressure.
- Constructive early coverage: Several firms began coverage with Buy ratings, and even the more cautious names hold targets well above the current price.
- Category tailwinds: Demand for organic, clean-label children's nutrition supports a premium positioning and shelf-space expansion.
Risks That Could Keep the Target Out of Reach
- Persistent losses: Continued negative EPS and negative levered free cash flow keep valuation dependent on future profitability that has not yet materialized.
- High short interest: Reported short interest near 26% of the public float indicates meaningful skepticism and can amplify volatility in either direction.
- Downward revisions: Barclays and Evercore ISI both cut their targets during 2026, a pattern that could continue if growth slows or losses widen.
- Post-IPO overhang: A steep decline from the $18 IPO price and the $27 high has damaged sentiment and left a large group of holders underwater.
Technical Levels Worth Watching
The $8.83-to-$9.00 area, touched in early November 2026, stands as the key near-term support level, while the $15-to-$16 band that held for months before the decline now acts as overhead resistance. Above that, the $18 IPO price and the $27.00 all-time high represent larger psychological and structural hurdles. Any durable recovery toward $16 would first require the stock to reclaim and hold the low-teens, a zone it briefly recaptured before slipping back.
Time Horizon and Key Items to Monitor
Analyst price targets generally reflect a forward-looking research horizon, commonly around 12 months, though firms differ in their assumptions. For OFRM, the most important near-term items are quarterly earnings and guidance, gross-margin trends in a higher-cost organic supply chain, and any further analyst target revisions. Investors should also watch short interest, fund flows in the small-cap consumer staples space, and whether the company can sustain its revenue growth rate while narrowing losses.
Final Assessment
The question of whether OFRM can reach $16 is ultimately a question of whether investors will again pay a growth premium for a fast-growing but unprofitable organic food brand. The average analyst target sits near $16.17, but the roughly 59% implied move reflects how far the stock has fallen rather than a consensus that the business is problem-free. Rapid revenue growth and a clean balance sheet support the bull case, while persistent losses, high short interest, and a string of analyst target cuts represent the principal obstacles. With targets still spanning a wide range and the most recent individual estimates clustered between $19 and $23, the path to $16 depends heavily on execution, profitability progress, and a stabilization of investor confidence. No outcome is guaranteed.
Using AI Tools for Deeper Analysis
In my own research process, I often turn to Tickeron’s AI Daily Buy/Sell Signals to get an additional layer of insight on names like this. The system scans thousands of stocks in real time, factoring in price action, technical patterns, and market structure to flag potential shifts. For a name with OFRM’s volatility and short interest, these signals have helped me stay attuned to day-to-day momentum without replacing fundamental work. It is one more data point I review alongside analyst notes and balance-sheet details.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Aroon Indicator for OFRM shows an upward move is likely
OFRM's Aroon Indicator triggered a bullish signal on October 29, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 10 similar instances where the Aroon Indicator showed a similar pattern. In 9 of the 10 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +10.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where OFRM advanced for three days, in 35 of 44 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
OFRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OFRM as a result. In 8 of 9 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for OFRM turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 4 similar instances when the indicator turned negative. In 3 of the 4 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
OFRM moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OFRM crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.504) is normal, around the industry mean (6.914). OFRM's P/E Ratio (-40.893) is considerably lower than the industry average of (7.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (2.382) is also within normal values, averaging (5.003).
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. OFRM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry FoodMajorDiversified
Advertisement